Lecithin and Pulmonary embolism - a phase IV clinical study of FDA data

Summary:

Pulmonary embolism is reported as a side effect among people who take Lecithin (phosphatidylcholine), especially for people who are female, 60+ old, also take Aranesp, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Pulmonary embolism when taking Lecithin. It is created by eHealthMe based on reports of 2,240 people who have side effects when taking Lecithin from the FDA, and is updated regularly.

What is Lecithin?

Lecithin has active ingredients of phosphatidylcholine. It is often used in high blood cholesterol. eHealthMe is studying from 2,310 Lecithin users. Check the latest studies of Lecithin.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,333 drugs and 2,956 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

On Jul, 14, 2026

2,240 people reported to have side effects when taking Lecithin.
Among them, 23 people (1.03%) have Pulmonary embolism.

Could Lecithin cause Pulmonary embolism?

Among these 23 people:

What is the gender of people who have Pulmonary embolism when taking Lecithin? *

female: 86.36 %
male: 13.64 %

What is the age of people who have Pulmonary embolism when taking Lecithin? *

What are other drugs people take besides Lecithin? *

What are other side effects people have besides Pulmonary embolism? *

Diarrhea: 17 people, 73.91%
Hypotension (abnormally low blood pressure): 17 people, 73.91%
Abdominal Pain: 16 people, 69.57%
Nausea And Vomiting: 16 people, 69.57%
Nausea (feeling of having an urge to vomit): 16 people, 69.57%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 16 people, 69.57%
Stress And Anxiety: 16 people, 69.57%
Swelling: 16 people, 69.57%
Dyspnea (difficult or laboured breathing): 16 people, 69.57%
General Physical Health Deterioration (weak health status): 16 people, 69.57%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 47.83%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 8.70%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 1 person, 4.35%
Bacterial Infection: 1 person, 4.35%
Blood Phosphorus Increased: 1 person, 4.35%
Blood Uric Acid Increased: 1 person, 4.35%
Cardiogenic Shock (inadequate circulation of blood): 1 person, 4.35%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 4.35%
Constipation: 1 person, 4.35%
Diabetes: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Lecithin and have Pulmonary embolism?

- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lecithin:

Lecithin (2,310 reports)

Browse all side effects of Lecithin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary embolism:

Pulmonary embolism (2,333 drugs)

Browse all the conditions that are associated with Pulmonary embolism:

Pulmonary embolism (2,956 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on phosphatidylcholine (the active ingredients of Lecithin) and Lecithin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.